Roche Holding AG ADR | |
Stock Exchange | Other OTC |
EPS |
$1.57 |
Market Cap |
$194.55 B |
Shares Outstanding |
5.62 B |
Public Float |
5.62 B |
Roche Holding AG Part. Cert. | |
Stock Exchange | Other OTC |
EPS |
$12.53 |
Market Cap |
$240.15 B |
Shares Outstanding |
702.56 M |
Public Float |
- |
Roche Holding AG | |
Stock Exchange | Other OTC |
EPS |
$12.53 |
Market Cap |
$239.38 B |
Shares Outstanding |
160 M |
Public Float |
- |
Roche Holding AG | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR10.52 |
Market Cap |
EUR213.61 B |
Shares Outstanding |
160 M |
Public Float |
- |
Roche Holding AG | |
Stock Exchange | Mexican Stock Exchange |
EPS |
MXN240.33 |
Market Cap |
MXN4.63 T |
Shares Outstanding |
- |
Public Float |
- |
Roche Holding AG Akt | |
Stock Exchange | SIX Swiss Exchange |
EPS |
CHF12.21 |
Market Cap |
CHF237.36 B |
Shares Outstanding |
160 M |
Public Float |
26.56 M |
Roche Holding AG | |
Stock Exchange | SIX Swiss Exchange |
EPS |
CHF12.18 |
Market Cap |
CHF205.36 B |
Shares Outstanding |
702.56 M |
Public Float |
693.36 M |
Address |
Grenzacherstrasse 124 Basel Basel-Stadt (Basle Town) 4070 Switzerland |
Employees | - |
Website | http://www.roche.com |
Updated | 09/14/2018 |
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. |